# Taylor Morrisette

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/taylor-morrisette/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,717 |
| Field | Antibiotics Pharmacokinetics and Efficacy |
| h-index | 27 |
| i10-index | 42 |
| Last Known Institution | Eugene Applebaum College of Pharmacy and Health Sciences |
| OpenAlex ID | https://openalex.org/A5005269906 |
| ORCID iD | 0000-0002-1094-043X |
| Works | 103 |

## Researcher papers

- [Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections](https://scholariq.org/papers/real-world-experience-with-ceftazidime-avibactam-for-multidrug-resistant-gram/)
- [Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations](https://scholariq.org/papers/bacteriophage-therapeutics-a-primer-for-clinicians-on-phage-antibiotic/)
- [On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections](https://scholariq.org/papers/on-and-off-label-utilization-of-dalbavancin-and-oritavancin-for-gram-positive/)
- [Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs](https://scholariq.org/papers/long-acting-lipoglycopeptides-lineless-antibiotics-for-serious-infections-in/)
- [Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus](https://scholariq.org/papers/bacteriophage-antibiotic-combination-strategy-an-alternative-against-methicillin/)
- [Current therapies and challenges for the treatment of <i>Staphylococcus aureus</i> biofilm‐related infections](https://scholariq.org/papers/current-therapies-and-challenges-for-the-treatment-of-i-staphylococcus-aureus-i/)
- [Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>](https://scholariq.org/papers/real-world-multicenter-experience-with-meropenem-vaborbactam-for-gram-negative/)
- [Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii](https://scholariq.org/papers/clinical-outcomes-of-eravacycline-in-patients-treated-predominately-for/)
- [Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections](https://scholariq.org/papers/real-world-experience-with-ceftolozane-tazobactam-for-multidrug-resistant-gram/)
- [Early Experience With Eravacycline for Complicated Infections](https://scholariq.org/papers/early-experience-with-eravacycline-for-complicated-infections/)
- [Management of Gram‐Negative Bloodstream Infections With Oral Antibiotics in Solid Organ Transplant Recipients](https://scholariq.org/papers/management-of-gram-negative-bloodstream-infections-with-oral-antibiotics-in/)

## Researcher topics

- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Bacteriophages and microbial interactions](https://scholariq.org/topics/bacteriophages-and-microbial-interactions/)

## Researcher university

- [Eugene Applebaum College of Pharmacy and Health Sciences](https://scholariq.org/institutions/eugene-applebaum-college-of-pharmacy-and-health-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.